Oligonucleotides, peptides, and protein sequencing are essential tools of modern molecular medicine and biology. Access to these tools is essential for investigation and diagnosis of genetic alterations linked to transformed cell states and to many infectious diseases. The DNA/Peptide Shared Resource provides a dependable, rapid, and affordable supply of synthetic DNA and RNA (oligonucleotides), peptides, and protein sequencing for Cancer Center members. Oligonucleotides are used in DNA sequencing, as polymerase chain reaction primers, for site-directed mutagenesis, and as probes for the identification of genetic information Modified oligonucleotides have been used for anti-sense experiments with direct therapeutic possibilities. Synthetic peptides are used as a direct means of exploring the function of, or to generate immunological agents against, specific regions of proteins. Protein sequencing is used to confirm the identify of proteins or to identify regions of amino acid sequence in proteins of interest. This facility provides these services in a fast, efficient manner that minimizes the cost to individual laboratories. It also provides low cost access to our instrumentation for researchers at the Center, should they develop reagents or techniques requiring it. This facility serves as an information source for Cancer Center members to find assistance with the design and implementation of specific types of experiments. Staff members are available to train Cancer Center members in a wide variety of DNA/Peptide techniques.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA042014-13
Application #
6334938
Study Section
Project Start
2000-07-25
Project End
2001-04-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
13
Fiscal Year
2000
Total Cost
$84,684
Indirect Cost
Name
University of Utah
Department
Type
DUNS #
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Fowler, Brynn; Samadder, N Jewel; Kepka, Deanna et al. (2018) Improvements in Colorectal Cancer Incidence Not Experienced by Nonmetropolitan Women: A Population-Based Study From Utah. J Rural Health 34:155-161
Grieshober, Laurie; Graw, Stefan; Barnett, Matt J et al. (2018) Methylation-derived Neutrophil-to-Lymphocyte Ratio and Lung Cancer Risk in Heavy Smokers. Cancer Prev Res (Phila) 11:727-734
Burch, Joseph S; Marcero, Jason R; Maschek, John Alan et al. (2018) Glutamine via ?-ketoglutarate dehydrogenase provides succinyl-CoA for heme synthesis during erythropoiesis. Blood 132:987-998
Guo, Jingtao; Grow, Edward J; Mlcochova, Hana et al. (2018) The adult human testis transcriptional cell atlas. Cell Res 28:1141-1157
Philip, Beatrice; Yu, Diana X; Silvis, Mark R et al. (2018) Mutant IDH1 Promotes Glioma Formation In Vivo. Cell Rep 23:1553-1564
Sadler, Jessica B A; Wenzel, Dawn M; Williams, Lauren K et al. (2018) A cancer-associated polymorphism in ESCRT-III disrupts the abscission checkpoint and promotes genome instability. Proc Natl Acad Sci U S A 115:E8900-E8908
Piñas, Germán E; DeSantis, Michael D; Parkinson, John S (2018) Noncritical Signaling Role of a Kinase-Receptor Interaction Surface in the Escherichia coli Chemosensory Core Complex. J Mol Biol 430:1051-1064
Rambau, Peter F; Vierkant, Robert A; Intermaggio, Maria P et al. (2018) Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study. J Pathol Clin Res 4:250-261
Stump, Tammy K; Aspinwall, Lisa G; Kohlmann, Wendy et al. (2018) Genetic Test Reporting and Counseling for Melanoma Risk in Minors May Improve Sun Protection Without Inducing Distress. J Genet Couns 27:955-967
Rogers, R Aaron; Fleming, Aaron M; Burrows, Cynthia J (2018) Unusual Isothermal Hysteresis in DNA i-Motif pH Transitions: A Study of the RAD17 Promoter Sequence. Biophys J 114:1804-1815

Showing the most recent 10 out of 1193 publications